Timo Liimatainen
Research Director
Department of Biotechnology and Molecular Medicine
University of Eastern Finland
Finland
Biography
Research Director and Medical Physicist trainee in the Department of Biotechnology and Molecular Medicine at University of Eastern Finland
Research Interest
Development of endogenous MRI contrasts Apply MRI to detect cardiovascular diseases and therapy responses
Publications
-
Laura Tuppurainen, Hanna Sallinen, Emmi Kokki, Jonna Koponen, Maarit Anttila, et al. (2013) Preclinical Safety, Toxicology, and Biodistribution Study of Adenoviral Gene Therapy with sVEGFR-2 and sVEGFR-3 Combined with Chemotherapy for Ovarian Cancer. Human Gene Therapy Clinical Development. 24: 29-37.
-
Laura Tuppurainen, Hanna Sallinen, Emmi Kokki, Jonna Koponen, Maarit Anttila, Kati Pulkkinen, Tommi Heikura, Pyry Toivanen, Kirsi Hämäläinen, Veli-Matti Kosma, Seppo Heinonen, Kari Alitalo, and Seppo Ylä-Herttuala. Human Gene Therapy Clinical Development. March 2013, 24(1): 29-37.
-
Hanne Hakkarainen, Alejandra Sierra, Silvia Mangia, Michael Garwood, Timo Liimatainen, et al. (2016) MRI Relaxation in the Presence of Fictitious Fields Correlate with Myelin Content in Normal Rat Brain. Magn Reson Med 75: 161–168.
-
Mikko P. Turunen , Tiia Husso , Haja Musthafa, Svetlana Laidinen, Timo Liimatainen, et al. (2014) Epigenetic Upregulation of Endogenous VEGF-A Reduces Myocardial Infarct Size in Mice. PLoS ONE 9: e89979.
